|
|
||||||||




*
Epimmune, Inc., San Diego, CA 92121;
Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada; and
Cytel Corporation, San Diego, CA 92121
Linear carbohydrate-peptide constructs based on the 13 amino acid nonnatural pan DR epitope (PADRE) and carbohydrate B cell epitopes are demonstrated to be potent immunogens. These data support our belief that PADRE should be considered as an alternative to more complex carriers for use in prophylaxis and therapeutic vaccines. Two model carbohydrate-PADRE glycoconjugates were used to demonstrate that PADRE could effectively provide T cell help for carbohydrate-specific Ab responses. Conjugates of PADRE covalently linked to the human milk oligosaccharide, lacto-N-fucopentose II or a dodecasaccharide derived from Salmonella typhimurium O-Ag induced high titer IgG Ab responses in mice, which were comparable to glycoconjugates employing human serum albumin (HSA) as the carrier protein. Different adjuvants, in combination with PADRE conjugates, allowed for the modulation of the isotype profile with alum supporting an IgG1 profile; QS-21 an IgG2a, 2b profile, while an alum/QS-21 mixture generated a balanced IgG1/IgG2b isotype profile. As defined by binding to synthetic glycoconjugates, dodecasaccharide-specific Abs exhibited fine specificity similar to protective polyclonal Ab responses previously reported for dodecasaccharide-protein conjugates. The same Abs bound to intact S. typhimurium cells, suggesting that biologically relevant specificities were produced. The affinity of the dodecasaccharide-specific Abs was further shown to be comparable to that of a well-characterized, high affinity monoclonal anti-carbohydrate Ab recognizing the same epitope.
This article has been cited by other articles:
![]() |
K. Baraldo, E. Mori, A. Bartoloni, F. Norelli, G. Grandi, R. Rappuoli, O. Finco, and G. Del Giudice Combined Conjugate Vaccines: Enhanced Immunogenicity with the N19 Polyepitope as a Carrier Protein Infect. Immun., September 1, 2005; 73(9): 5835 - 5841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Agadjanyan, A. Ghochikyan, I. Petrushina, V. Vasilevko, N. Movsesyan, M. Mkrtichyan, T. Saing, and D. H. Cribbs Prototype Alzheimer's Disease Vaccine Using the Immunodominant B Cell Epitope from {beta}-Amyloid and Promiscuous T Cell Epitope Pan HLA DR-Binding Peptide J. Immunol., February 1, 2005; 174(3): 1580 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baraldo, E. Mori, A. Bartoloni, R. Petracca, A. Giannozzi, F. Norelli, R. Rappuoli, G. Grandi, and G. Del Giudice N19 Polyepitope as a Carrier for Enhanced Immunogenicity and Protective Efficacy of Meningococcal Conjugate Vaccines Infect. Immun., August 1, 2004; 72(8): 4884 - 4887. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Vyas, M. N. Vyas, M. C. Chervenak, D. R. Bundle, B. M. Pinto, and F. A. Quiocho Structural basis of peptide-carbohydrate mimicry in an antibody-combining site PNAS, December 9, 2003; 100(25): 15023 - 15028. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Decroix, P. Pamonsinlapatham, C. P. Quan, and J.-P. Bouvet Impairment by Mucosal Adjuvants and Cross-Reactivity with Variant Peptides of the Mucosal Immunity Induced by Injection of the Fusion Peptide PADRE-ELDKWA Clin. Vaccine Immunol., November 1, 2003; 10(6): 1103 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amir-Kroll, G. Nussbaum, and I. R. Cohen Proteins and Their Derived Peptides as Carriers in a Conjugate Vaccine for Streptococcus pneumoniae: Self-Heat Shock Protein 60 and Tetanus Toxoid J. Immunol., June 15, 2003; 170(12): 6165 - 6171. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Goetsch, J. F. Haeuw, T. Champion, C. Lacheny, T. N'Guyen, A. Beck, and N. Corvaia Identification of B- and T-Cell Epitopes of BB, a Carrier Protein Derived from the G Protein of Streptococcus Strain G148 Clin. Vaccine Immunol., January 1, 2003; 10(1): 125 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Castelli, C. Buhot, A. Sanson, H. Zarour, S. Pouvelle-Moratille, C. Nonn, H. Gahery-Segard, J.-G. Guillet, A. Menez, B. Georges, et al. HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity J. Immunol., December 15, 2002; 169(12): 6928 - 6934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |